MDT

88.92

+1.08%↑

VEEV

280.87

-0.93%↓

A

121.84

+2.04%↑

WBA

11.51

+0.09%↑

HQY

103.3

+1.29%↑

MDT

88.92

+1.08%↑

VEEV

280.87

-0.93%↓

A

121.84

+2.04%↑

WBA

11.51

+0.09%↑

HQY

103.3

+1.29%↑

MDT

88.92

+1.08%↑

VEEV

280.87

-0.93%↓

A

121.84

+2.04%↑

WBA

11.51

+0.09%↑

HQY

103.3

+1.29%↑

MDT

88.92

+1.08%↑

VEEV

280.87

-0.93%↓

A

121.84

+2.04%↑

WBA

11.51

+0.09%↑

HQY

103.3

+1.29%↑

MDT

88.92

+1.08%↑

VEEV

280.87

-0.93%↓

A

121.84

+2.04%↑

WBA

11.51

+0.09%↑

HQY

103.3

+1.29%↑

Search

Dynavax Technologies Corp

Geschlossen

BrancheGesundheitswesen

10.45 3.26

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

10.1

Max

10.42

Schlüsselkennzahlen

By Trading Economics

Einkommen

-103M

-96M

Verkäufe

-3.9M

68M

KGV

Branchendurchschnitt

58.75

40.527

Gewinnspanne

-140.982

Angestellte

405

EBITDA

-106M

-94M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+114.22% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

5. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-477M

1.2B

Vorheriger Eröffnungskurs

7.19

Vorheriger Schlusskurs

10.45

Nachrichtenstimmung

By Acuity

50%

50%

143 / 375 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

Dynavax Technologies Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

7. Juli 2025, 15:29 UTC

Wichtige Markttreiber

Mustang Bio Shares Jump After Orphan Drug Designation for Cancer Treatment

7. Juli 2025, 23:44 UTC

Market Talk

Nikkei May Fall on U.S. Tariff Concerns -- Market Talk

7. Juli 2025, 23:44 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7. Juli 2025, 23:41 UTC

Market Talk

Gold Edges Lower Amid Hopes for Possible Trade Agreements -- Market Talk

7. Juli 2025, 23:19 UTC

Market Talk

Global Equities Roundup: Market Talk

7. Juli 2025, 23:19 UTC

Market Talk

AML3D Bull Sees Navy Letter Lowering Risks -- Market Talk

7. Juli 2025, 22:20 UTC

Market Talk

Global Equities Roundup: Market Talk

7. Juli 2025, 22:20 UTC

Market Talk

AT&T's Fiber Strategy Positions Stock to Outperform -- Market Talk

7. Juli 2025, 21:34 UTC

Akquisitionen, Fusionen, Übernahmen

BlackRock's Latest Acquisition Is a Commercial Real Estate Bet -- Barrons.com

7. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

7. Juli 2025, 20:45 UTC

Akquisitionen, Fusionen, Übernahmen

CoreWeave Is Buying Core Scientific. The CEO Explains Why. -- Barrons.com

7. Juli 2025, 20:16 UTC

Market Talk

Canada Bonds Set to Benefit From Rotation Away U.S. Assets -- Market Talk

7. Juli 2025, 19:37 UTC

Market Talk

U.S. Natural Gas Futures Hold Their Ground -- Market Talk

7. Juli 2025, 19:12 UTC

Market Talk

Oil Futures Shrug Off Bigger OPEC+ Output Increase -- Market Talk

7. Juli 2025, 18:33 UTC

Market Talk

Gold Flat as Investors Assess Market Direction -- Market Talk

7. Juli 2025, 18:27 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7. Juli 2025, 16:53 UTC

Ergebnisse

Freight Stocks Have a Tariff Overhang. Morgan Stanley Says It Could Be Worse. -- Barrons.com

7. Juli 2025, 16:30 UTC

Market Talk

Higher Prices Limit Power Sector's Natural Gas Use -- Market Talk

7. Juli 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

7. Juli 2025, 16:05 UTC

Akquisitionen, Fusionen, Übernahmen

CoreWeave Is Buying Core Scientific. The CEO Explains Why. -- Barrons.com

7. Juli 2025, 15:41 UTC

Market Talk

Gold Futures Fall as Stronger U.S. Dollar Undermines Safe-Haven Demand -- Market Talk

7. Juli 2025, 15:41 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

7. Juli 2025, 15:40 UTC

Market Talk

Base Metal Prices Tick Lower on U.S. Dollar Strength -- Market Talk

7. Juli 2025, 15:30 UTC

Market Talk

Physical Oil Market Stable But Structural Weakness Looms -- Market Talk

7. Juli 2025, 15:18 UTC

Market Talk

BNP Cuts Brent Forecast on U.S. Shale, Iran Supply Resilience -- Market Talk

7. Juli 2025, 15:14 UTC

Akquisitionen, Fusionen, Übernahmen

MicroStrategy Goes a Week Without Buying Bitcoin. Saylor Has Advice for Crypto Traders. -- Barrons.com

7. Juli 2025, 15:00 UTC

Akquisitionen, Fusionen, Übernahmen

GSK Completes Acquisition of Efimosfermin

7. Juli 2025, 14:52 UTC

Market Talk

Dollar Faces Downward Pressures Stemming from Tariffs -- Market Talk

7. Juli 2025, 14:51 UTC

Market Talk

Bullish Factors Lift Oil Despite Downward Pressure -- Market Talk

7. Juli 2025, 14:45 UTC

Market Talk

Saudi Arabia Not Seeking to Take Oil Market Share -- Market Talk

Peer-Vergleich

Kursveränderung

Dynavax Technologies Corp Prognose

Kursziel

By TipRanks

114.22% Vorteil

12-Monats-Prognose

Durchschnitt 22 USD  114.22%

Hoch 31 USD

Tief 10 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Dynavax Technologies Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

4 ratings

3

Buy

0

Halten

1

Sell

Technischer Score

By Trading Central

9.62 / 10.9Unterstützung & Widerstand

Kurzfristig

Very Strong Bearish Evidence

Mittelfristig

Very Strong Bearish Evidence

Langfristig

Strong Bearish Evidence

Stimmung

By Acuity

143 / 375 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Dynavax Technologies Corp

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.